{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:00:17Z","timestamp":1793919617361,"version":"4.8.0"},"reference-count":38,"publisher":"Walter de Gruyter GmbH","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Birjand University of Medical Sciences","award":["6777"],"award-info":[{"award-number":["6777"]}],"id":[{"id":"https:\/\/ror.org\/01h2hg078","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Birjand University of Medical Sciences","award":["457450"],"award-info":[{"award-number":["457450"]}],"id":[{"id":"https:\/\/ror.org\/01h2hg078","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_hmbci-2026-0013_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      Hyperplastic skin disorders such as psoriasis are characterized by excessive keratinocyte proliferation, impaired apoptosis, oxidative stress, and sustained activation of innate immune pathways. While conventional treatment primarily targets these mechanisms, emerging interest focuses on the immunomodulatory roles of sex hormones such as progesterone (P4). Clinical observations that psoriasis symptoms often improve during pregnancy, when P4 levels increase, further support this hypothesis. However, the direct effects of P4 on keratinocyte behavior and related molecular pathways remain poorly understood. The study aimed to evaluate the impact of P4 on key pathological features of keratinocytes using the HaCaT\u00a0cell line as an\n                      <jats:italic>in\u00a0vitro<\/jats:italic>\n                      \u00a0model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2026-0013_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      HaCaT\u00a0cells were cultured in DMEM medium with 10\u202f% FBS and 1\u202f% penicillin\/streptomycin. Cells treated with various concentrations of P4, as well as untreated controls, were incubated at 37\u202f\u00b0C incubator with 5\u202f% CO\n                      <jats:sub>2<\/jats:sub>\n                      for 1\u20133\u00a0days. Following treatment, cell viability, apoptosis, oxidative stress, and Toll-like receptor 2 (TLR2) expression were assessed using MTT assay and flow cytometry.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2026-0013_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>P4 significantly reduces keratinocyte proliferation and promotes apoptosis. Moreover, it also decreased intracellular reactive oxygen species (ROS) levels and downregulated TLR2 surface expression (p value\u22640.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2026-0013_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      These findings highlight the multifaceted ability of P4 to modulate keratinocyte biology by regulating proliferation, apoptosis, oxidative balance, and inflammatory signaling. Interestingly, these effects occurred despite the absence of specific membrane P4 receptors, suggesting alternative pathways may mediate its actions. Further investigations under inflammatory conditions and\n                      <jats:italic>in\u00a0vivo<\/jats:italic>\n                      models are warranted to validate these results and explore potential therapeutic applications.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/hmbci-2026-0013","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:55:30Z","timestamp":1787115330000},"source":"Crossref","is-referenced-by-count":1,"title":["Dual effects of progesterone on HaCaT human keratinocytes: apoptosis induction and suppression of oxidative stress and TLR2 expression with potential implications for hyperplastic skin disorders"],"prefix":"10.1515","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7333-2789","authenticated-orcid":false,"given":"Seyedeh Sindokht","family":"Hosseini","sequence":"first","affiliation":[{"name":"Student Research Committee, Birjand University of Medical Sciences , Birjand , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Akbari","sequence":"additional","affiliation":[{"name":"Student Research Committee, Birjand University of Medical Sciences , Birjand , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somaye","family":"Karimi","sequence":"additional","affiliation":[{"name":"Student Research Committee, Birjand University of Medical Sciences , Birjand , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2576-9452","authenticated-orcid":false,"given":"Mohammad","family":"Fereidouni","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Research Center, Birjand University of Medical Sciences , Birjand , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Anani-Sarab","sequence":"additional","affiliation":[{"name":"Department of Medical Immunology, School of Medicine , Birjand University of Medical Sciences , Birjand , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Sereshki","sequence":"additional","affiliation":[{"name":"Department of Immunology, School of Medicine , Isfahan University of Medical Sciences , Isfahan , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Rafiee","sequence":"additional","affiliation":[{"name":"Department of Immunology, School of Medicine , Cellular and Molecular Research Center, Birjand University of Medical Sciences , Birjand , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"2026092407553821378_j_hmbci-2026-0013_ref_001","doi-asserted-by":"crossref","unstructured":"Gratton, R, Del Vecchio, C, Zupin, L, Crovella, S. Unraveling the role of\u00a0sex hormones on keratinocyte functions in human inflammatory skin diseases. Int J Mol Sci 2022;23. https:\/\/doi.org\/10.3390\/ijms23063132.","DOI":"10.3390\/ijms23063132"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_002","doi-asserted-by":"crossref","unstructured":"Gratton, R, Tricarico, PM, Moltrasio, C, Lima Estev\u00e3o de Oliveira, AS, Brand\u00e3o, L, Marzano, AV, et al.. pleiotropic role of notch signaling in human skin diseases. Int J Mol Sci 2020;21. https:\/\/doi.org\/10.3390\/ijms21124214.","DOI":"10.3390\/ijms21124214"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_003","doi-asserted-by":"crossref","unstructured":"Watt, FM. Mammalian skin cell biology: at the interface between laboratory and clinic. Science 2014;346:937\u201340. https:\/\/doi.org\/10.1126\/science.1253734.","DOI":"10.1126\/science.1253734"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_004","doi-asserted-by":"crossref","unstructured":"Greb, JE, Goldminz, AM, Elder, JT, Lebwohl, MG, Gladman, DD, Wu, JJ, et al.. Psoriasis. Nat Rev Dis Primers 2016;2:16082. https:\/\/doi.org\/10.1038\/nrdp.2016.82.","DOI":"10.1038\/nrdp.2016.82"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_005","doi-asserted-by":"crossref","unstructured":"Perera, GK, Di Meglio, P, Nestle, FO. Psoriasis. Annu Rev Pathol 2012;7:385\u2013422. https:\/\/doi.org\/10.1146\/annurev-pathol-011811-132448.","DOI":"10.1146\/annurev-pathol-011811-132448"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_006","doi-asserted-by":"crossref","unstructured":"Hu, J, Bian, Q, Ma, X, Xu, Y, Gao, J. A double-edged sword: ROS related therapies in the treatment of psoriasis. Asian J Pharm Sci 2022;17:798\u2013816. https:\/\/doi.org\/10.1016\/j.ajps.2022.10.005.","DOI":"10.1016\/j.ajps.2022.10.005"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_007","unstructured":"Kumar, V. Going, Toll-like receptors in skin inflammation and inflammatory diseases. EXCLI J 2021;20:52\u201379. https:\/\/doi.org\/10.17179\/excli2020-3114."},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_008","doi-asserted-by":"crossref","unstructured":"Hellberg, S, Raffetseder, J, Rundquist, O, Magnusson, R, Papapavlou, G, Jenmalm, MC, et al.. Progesterone dampens immune responses in in\u00a0vitro activated CD4+ T\u00a0cells and affects genes associated with autoimmune diseases that improve during pregnancy. Front Immunol. 2021;12 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.672168.","DOI":"10.3389\/fimmu.2021.672168"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_009","doi-asserted-by":"crossref","unstructured":"Raghupathy, R, Szekeres-Bartho, J. Progesterone: a unique hormone with immunomodulatory roles in pregnancy. Int J Mol Sci 2022;23. https:\/\/doi.org\/10.3390\/ijms23031333.","DOI":"10.3390\/ijms23031333"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_010","unstructured":"Lee, EB, Wu, KK, Lee, MP, Bhutani, T, Wu, JJ. Psoriasis risk factors and triggers. Cutis 2018;102:18\u201320."},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_011","doi-asserted-by":"crossref","unstructured":"Ferreira, C, Azevedo, A, Nogueira, M, Torres, T. Management of psoriasis in pregnancy\u00a0\u2013\u00a0a review of the evidence to date. Drugs Context 2020;9. https:\/\/doi.org\/10.7573\/dic.2019-11-6.","DOI":"10.7573\/dic.2019-11-6"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_012","doi-asserted-by":"crossref","unstructured":"Simionescu, AA, Danciu, BM, Stanescu, AMA. State-of-the-Art review of pregnancy-related psoriasis. Medicina (Kaunas, Lithuania) 2021;57. https:\/\/doi.org\/10.3390\/medicina57080804.","DOI":"10.3390\/medicina57080804"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_013","doi-asserted-by":"crossref","unstructured":"Lee, JH, Ulrich, B, Cho, J, Park, J, Kim, CH. Progesterone promotes differentiation of human cord blood fetal T\u00a0cells into T regulatory cells but suppresses their differentiation into Th17 cells. J\u00a0Immunol 2011;187:1778\u201387. https:\/\/doi.org\/10.4049\/jimmunol.1003919.","DOI":"10.4049\/jimmunol.1003919"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_014","doi-asserted-by":"crossref","unstructured":"Arruvito, L, Giulianelli, S, Flores, AC, Paladino, N, Barboza, M, Lanari, C, et al.. NK cells expressing a progesterone receptor are susceptible to progesterone-induced apoptosis. J\u00a0Immunol 2008;180:5746\u201353. https:\/\/doi.org\/10.4049\/jimmunol.180.8.5746.","DOI":"10.4049\/jimmunol.180.8.5746"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_015","doi-asserted-by":"crossref","unstructured":"Dressing, GE, Alyea, R, Pang, Y, Thomas, P. Membrane progesterone receptors (mPRs) mediate progestin induced antimorbidity in breast cancer cells and are expressed in human breast tumors. Horm Cancer 2012;3:101\u201312. https:\/\/doi.org\/10.1007\/s12672-012-0106-x.","DOI":"10.1007\/s12672-012-0106-x"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_016","doi-asserted-by":"crossref","unstructured":"Zhu, Y, Bond, J, Thomas, P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci U S A 2003;100:2237\u201342. https:\/\/doi.org\/10.1073\/pnas.0436133100.","DOI":"10.1073\/pnas.0436133100"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_017","doi-asserted-by":"crossref","unstructured":"Bagheri, V, Rezaei, F, Alipour, R, Sereshki, N, Ahmadipanah, V, Rafiee, M. Progesterone decreases viability and up regulates membrane progesterone receptors expression on the human chronic myeloid leukemia cell line. Cancer Genet 2024;288-289:114\u20137. https:\/\/doi.org\/10.1016\/j.cancergen.2024.10.006.","DOI":"10.1016\/j.cancergen.2024.10.006"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_018","unstructured":"Formby, B, Wiley, TS. Progesterone inhibits growth and induces apoptosis in breast cancer cells: inverse effects on Bcl-2 and p53. Ann Clin Lab Sci 1998;28:360\u20139."},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_019","doi-asserted-by":"crossref","unstructured":"Motamed, HR, Shariati, M, Ahmadi, R, Khatamsaz, S, Mokhtari, M. The apoptotic effects of progesterone on breast cancer (MCF-7) and human osteosarcoma (MG-636) cells. Physiol Int 2020;107:406\u201318. https:\/\/doi.org\/10.1556\/2060.2020.00034.","DOI":"10.1556\/2060.2020.00034"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_020","doi-asserted-by":"crossref","unstructured":"Raghupathy, R, Al Mutawa, E, Makhseed, M, Azizieh, F, Szekeres-Bartho, J. Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage. BJOG 2005;112:1096\u2013101. https:\/\/doi.org\/10.1111\/j.1471-0528.2005.00633.x.","DOI":"10.1111\/j.1471-0528.2005.00633.x"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_021","doi-asserted-by":"crossref","unstructured":"Wang, WM, Jin, HZ. Role of neutrophils in psoriasis. J\u00a0Immunol Res 2020;2020:3709749. https:\/\/doi.org\/10.1155\/2020\/3709749.","DOI":"10.1155\/2020\/3709749"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_022","doi-asserted-by":"crossref","unstructured":"Dilek, N, Dilek, AR, Ta\u015fk\u0131n, Y, Erkin\u00fcresin, T, Yal\u00e7\u0131n, \u00d6, Saral, Y. Contribution of myeloperoxidase and inducible nitric oxide synthase to pathogenesis of psoriasis. Postepy Dermatol Alergol 2016;33:435\u20139. https:\/\/doi.org\/10.5114\/ada.2016.63882.","DOI":"10.5114\/ada.2016.63882"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_023","doi-asserted-by":"crossref","unstructured":"Zhao, Y, Ye, X, Xiong, Z, Ihsan, A, Ares, I, Mart\u00ednez, M, et al.. Cancer metabolism: the role of ROS in DNA damage and induction of apoptosis in cancer cells. Metabolites 2023;13. https:\/\/doi.org\/10.3390\/metabo13070796.","DOI":"10.3390\/metabo13070796"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_024","doi-asserted-by":"crossref","unstructured":"Irwin, RW, Yao, J, Hamilton, RT, Cadenas, E, Brinton, RD, Nilsen, J. Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Endocrinology 2008;149:3167\u201375. https:\/\/doi.org\/10.1210\/en.2007-1227.","DOI":"10.1210\/en.2007-1227"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_025","unstructured":"Carrasco, S, Neves, FS, Fonseca, MH, Gon\u00e7alves, CR, Saad, CG, Sampaio-Barros, PD, et al.. Toll-like receptor (TLR) 2 is upregulated on peripheral blood monocytes of patients with psoriatic arthritis: a role for a Gram-positive inflammatory trigger? Clin Exp Rheumatol 2011;29:958\u201362."},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_026","doi-asserted-by":"crossref","unstructured":"Choudhary, V, Griffith, S, Chen, X, Bollag, WB. Pathogen-associated molecular pattern-induced TLR2 and TLR4 activation increases keratinocyte production of inflammatory mediators and is inhibited by phosphatidylglycerol. Mol Pharmacol 2020;97:324\u201335. https:\/\/doi.org\/10.1124\/mol.119.118166.","DOI":"10.1124\/mol.119.118166"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_027","doi-asserted-by":"crossref","unstructured":"Shehata, W, Hammam, M, Seif, D, Elsayed, S, Maqsoud, E, El-Hefnawy, S. Role of toll-like receptor 4 gene expression in psoriasis and its relation to disease activity. Menoufia Med J 2022;35. https:\/\/doi.org\/10.4103\/mmj.mmj_157_21.","DOI":"10.4103\/mmj.mmj_157_21"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_028","doi-asserted-by":"crossref","unstructured":"G\u00fcrel, G, Sabah-\u00d6zcan, S. Evaluation of toll-like receptor expression profile in patients with psoriasis vulgaris. Gene 2019;702:166\u201370. https:\/\/doi.org\/10.1016\/j.gene.2019.03.058.","DOI":"10.1016\/j.gene.2019.03.058"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_029","doi-asserted-by":"crossref","unstructured":"Wullaert, A, Bonnet, MC, Pasparakis, M. NF-\u03baB in the regulation of epithelial homeostasis and inflammation. Cell Res 2011;21:146\u201358. https:\/\/doi.org\/10.1038\/cr.2010.175.","DOI":"10.1038\/cr.2010.175"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_030","doi-asserted-by":"crossref","unstructured":"Huang, TH, Lin, CF, Alalaiwe, A, Yang, SC, Fang, JY. Apoptotic or antiproliferative activity of natural products against keratinocytes for the treatment of psoriasis. Int J Mol Sci 2019;20. https:\/\/doi.org\/10.3390\/ijms20102558.","DOI":"10.3390\/ijms20102558"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_031","doi-asserted-by":"crossref","unstructured":"Thomas, P. Membrane progesterone receptors (mPRs, PAQRs): review of structural and signaling characteristics. Cells 2022;11. https:\/\/doi.org\/10.3390\/cells11111785.","DOI":"10.1210\/endocr\/bqac147"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_032","doi-asserted-by":"crossref","unstructured":"Im, S, Lee, ES, Kim, W, Song, J, Kim, J, Lee, M, et al.. Expression of progesterone receptor in human keratinocytes. J\u00a0Kor Med Sci 2000;15:647\u201354. https:\/\/doi.org\/10.3346\/jkms.2000.15.6.647.","DOI":"10.3346\/jkms.2000.15.6.647"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_033","doi-asserted-by":"crossref","unstructured":"Asavasupreechar, T, Saito, R, Miki, Y, Edwards, DP, Boonyaratanakornkit, V, Sasano, H. Systemic distribution of progesterone receptor subtypes in human tissues. J\u00a0Steroid Biochem Mol Biol 2020;199:105599. https:\/\/doi.org\/10.1016\/j.jsbmb.2020.105599.","DOI":"10.1016\/j.jsbmb.2020.105599"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_034","doi-asserted-by":"crossref","unstructured":"Murtha, A, Grotegut, C, Heine, RP, Feng, L. 46: progesterone receptor membrane component 1 (PGRMC1) inhibits Ca2+ mediated cell death\u00a0in human cytotrophoblast cells. Am J Obstet Gynecol 2011;204:S27. https:\/\/doi.org\/10.1016\/j.ajog.2010.10.057.","DOI":"10.1016\/j.ajog.2010.10.057"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_035","doi-asserted-by":"crossref","unstructured":"Pedro, MP, Salinas Parra, N, Gutkind, JS, Iglesias-Bartolome, R. Activation of G-protein coupled receptor-G\u03b1i signaling increases keratinocyte proliferation and reduces differentiation, leading to epidermal hyperplasia. J\u00a0Invest Dermatol 2020;140:1195\u2013203.e3. https:\/\/doi.org\/10.1016\/j.jid.2019.10.012.","DOI":"10.1016\/j.jid.2019.10.012"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_036","doi-asserted-by":"crossref","unstructured":"Thejer, BM, Adhikary, PP, Kaur, A, Teakel, SL, Van Oosterum, A, Seth, I, et al.. PGRMC1 phosphorylation affects cell shape, motility, glycolysis, mitochondrial form and function, and tumor growth. BMC Mol Cell Biol 2020;21:24. https:\/\/doi.org\/10.1186\/s12860-020-00256-3.","DOI":"10.1186\/s12860-020-00256-3"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_037","doi-asserted-by":"crossref","unstructured":"Chen, C, Chen, L, Zhou, J, Cai, R, Ye, Z, Zhang, D. Anti-psoriasis activities of hydroxytyrosol on HaCaT\u00a0cells under psoriatic inflammation in\u00a0vitro. Immunopharmacol Immunotoxicol 2023;45:328\u201333. https:\/\/doi.org\/10.1080\/08923973.2022.2143373.","DOI":"10.1080\/08923973.2022.2143373"},{"key":"2026092407553821378_j_hmbci-2026-0013_ref_038","doi-asserted-by":"crossref","unstructured":"Van Den Bogaard, EH, Tjabringa, GS, Joosten, I, Vonk-Bergers, M, Van Rijssen, E, Tijssen, HJ, et al.. Crosstalk between keratinocytes and T\u00a0cells in a 3D microenvironment: a model to study inflammatory skin diseases. J\u00a0Invest Dermatol 2014;134:719\u201327. https:\/\/doi.org\/10.1038\/jid.2013.417.","DOI":"10.1038\/jid.2013.417"}],"container-title":["Hormone Molecular Biology and Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2026-0013\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2026-0013\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:55:55Z","timestamp":1790236555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2026-0013\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":38,"alternative-id":["10.1515\/hmbci-2026-0013"],"URL":"https:\/\/doi.org\/10.1515\/hmbci-2026-0013","relation":{},"ISSN":["1868-1883","1868-1891"],"issn-type":[{"value":"1868-1883","type":"print"},{"value":"1868-1891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]}}}